Organization and Description of Business (Narrative) (Details) $ / shares in Units, $ in Millions			12 Months Ended
	Oct. 06, 2021 USD ($)	Oct. 05, 2021	Dec. 31, 2022 company $ / shares	Oct. 31, 2022 $ / shares	Dec. 31, 2021 $ / shares
Number of partner companies that are publicly traded | company			4
Common Stock, par value | $ / shares			$ 0.001	$ 0.001	$ 0.001
Number of partner companies that have consummated strategic partnerships with industry leaders | company			3
Maximum
Bid price of common stock | $ / shares				$ 1.00
Caelum | AstraZeneca [Member]
Deconsolidation of consolidated partner company, percentage deconsolidated	100.00%	100.00%
Deconsolidation of consolidated partner company, upfront payment | $	$ 150
Caelum | AstraZeneca [Member] | Maximum
Deconsolidation of consolidated partner company, contingent payment | $	$ 350